Skip to content

Sonoco Products SON Asset write-downs

Asset write-downs at other companies

Smurfit Kappa Group logo
Smurfit Kappa GroupSW
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Constellium logo
ConstelliumCSTM
Westlake logo
WestlakeWLK

Other financials

Income statement

See full
Revenue$1.7B-1.9%
Gross profit$345.6M-2.3%
Operating income$127.1M+0.2%
Net income$67.6M+24.2%
EPS (diluted)$0.68+23.6%

Balance sheet

See full
Cash & equivalents$224.5M+17.1%
Total debt$6.3B-35.2%
Total equity$3.6B+45.8%
Total assets$11.1B-12.7%

Cash flow

See full
Operating cash flow-$367.9M-76.8%
CapEx$62.1M-33.0%
Free cash flow-$430.0M-43.0%

Valuation

See full
Market cap$5.01B+14.5%
Enterprise value$11.05B-19.5%
P/E4.9×-23.6×
P/S0.7×-0.1×

Profitability

See full
Gross margin20.9%-0.5pp
Operating margin13.6%+6.9pp
Net margin13.6%+10.9pp
FCF margin2.9%+1.8pp

Returns & leverage

See full
Return on equity33.8%+27.5pp
Debt / equity1.8×-2.2×
Current ratio+0.2×

Where this comes from

Reported directly by Sonoco Products in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The official record: Sonoco Products’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sonoco Products's asset write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sonoco Products's asset write-downs?
Sonoco Products (SON) reported asset write-downs of $3.09M in Q1 2026.
How has Sonoco Products's asset write-downs changed year-over-year?
Sonoco Products's asset write-downs decreased by 37.6% year-over-year, from $4.95M to $3.09M.
What is the long-term trend for Sonoco Products's asset write-downs?
Over 3 years (2021 to 2025), Sonoco Products's asset write-downs has grown at a 45.3% compound annual growth rate (CAGR), from -$4.08M to $12.53M.